{
    "nctId": "NCT02052115",
    "briefTitle": "Behavioral Weight Loss and Exercise After Treatment (BEAT)",
    "officialTitle": "Behavioral Weight Loss and Exercise After Treatment (BEAT): Predictors of Weight Loss Success in Overweight Breast Cancer Survivors",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Correlation of executive function and weight loss success",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer diagnosis\n* Received surgery +/- chemotherapy +/- radiation for treatment of a Stage I, II or III breast cancer. Ongoing treatment with monoclonal antibodies and/or anti-estrogen therapy is acceptable\n* Completion of initial therapy 6 weeks prior to study initiation\n* BMI of 27-45 kg/m\\^2\n\nExclusion Criteria:\n\n* Prior diagnosis of malignancy other than non-melanoma skin cancer (i.e. prior non-melanoma skin cancer is not an exclusion criteria)\n* Medical conditions that limit food choices such as celiac sprue or inflammatory bowel disease\n* Inability to walk on flat ground (or a treadmill) at 2.5 mph for 5 minutes\n* Age \\<21 and \\>70\n* Presence of body metal\n* Psychotic or central nervous system impairment that would limit compliance with study requirements, including dementia\n* Evidence of metastatic disease\n* Symptomatic heart disease (chest pain or equivalent with activity)\n* Exercise limiting pulmonary disease or need for oxygen to exercise\n* Individuals taking mood stabilizing medications including: Lithium, valproic acid, also called divalproex sodium (Depakote), carbamazepine (Tegretol), lamotrigine (Lamictal), oxcarbazepine (Trileptal), olanzapine (Zyprexa), aripiprazole (Abilify), risperidone (Risperdal), ziprasidone (Geodon), clozapine (clorazil)\n* Participants with an active neurologic disorder that affects the central nervous system, including seizures, and Parkinson's disease\n* Weight loss of \\>10 lbs in the previous 6 months\n* Participation in \\> 150 minutes of moderate intensity activity by self report, unless activity level by accelerometer is less than 150 minutes of moderate intensity activity",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}